About
LipoCure is developing a number of therapeutics utilizing proprietary liposome-based nano drugs with novel drug-loading capabilities and drug-release mechanisms. LipoCure's proprietary platform implements an approach that allows for remote drug loading into nano-liposomes and concomitant controlled release of the drugs at the targeted site. This technology is designed to produce an enhanced permeability and retention effect, a significantly improved therapeutic effect, and reduced side effects. It can be used in conjunction with several well-established drugs used for the treatment of rheumatoid arthritis, multiple sclerosis, and cancer. LipoCure's founder is professor Yechezkel Barenholz, the co-developer of Doxil.
Funding history · 1 round · $8.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is LipoCure's primary focus in drug development?
- LipoCure is developing therapeutics using proprietary liposome-based nano drugs with novel drug-loading capabilities and drug-release mechanisms.
- When was LipoCure founded?
- LipoCure was founded in November 2005.
- Who is the founder of LipoCure and what is their notable past achievement?
- LipoCure's founder is Professor Yechezkel Barenholz, who is also the co-developer of Doxil.
- What was LipoCure's last funding round, and how much was raised?
- In September 2017, LipoCure completed a Series A funding round, raising $8,000,000.
- Which investors participated in LipoCure's Series A funding round?
- LipoCure's Series A funding round included investments from Integra Holdings and Yechezkel Barenholz.
- How many employees does LipoCure currently have?
- LipoCure currently has 8 employees.
- What is the status of LipoCure's product development?
- LipoCure's product development is currently in the clinical trial stage.
- Which company licensed LipoCure's liposome drug delivery technology?
- In June 2018, Virpax Pharmaceuticals licensed liposome drug delivery technology from LipoCure.
- What types of diseases are LipoCure's technologies designed to treat?
- LipoCure's technology can be used with established drugs for the treatment of rheumatoid arthritis, multiple sclerosis, and cancer.